Browse
Submit Data
Databases
API
Help

Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression in adipose tissues of polygenic Fat mice

ABSTRACT: Gene expression in adipose and other tissues of polygenic Fat and Lean mice.

ORGANISM(S): Mus musculus

SUBMITTER: Donald Dunbar

PROVIDER: E-MEXP-3091 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Publications

A stratified transcriptomics analysis of polygenic fat and lean mouse adipose tissues identifies novel candidate obesity genes.

Morton Nicholas M NM Nelson Yvonne B YB Michailidou Zoi Z Di Rollo Emma M EM Ramage Lynne L Hadoke Patrick W F PW Seckl Jonathan R JR Bunger Lutz L Horvat Simon S Kenyon Christopher J CJ Dunbar Donald R DR

PloS one 20110907 9

<h4>Background</h4>Obesity and metabolic syndrome results from a complex interaction between genetic and environmental factors. In addition to brain-regulated processes, recent genome wide association studies have indicated that genes highly expressed in adipose tissue affect the distribution and function of fat and thus contribute to obesity. Using a stratified transcriptome gene enrichment approach we attempted to identify adipose tissue-specific obesity genes in the unique polygenic Fat (F) m ...[more]

PMID: 21915269

Similar Datasets

Transcription profiling by array of mouse kidneys following chronic ACTH treatment or control treatment

Project description:This experiment compares gene expression in kidneys of control and ACTH treated mice. <br>Kidney RNA was prepared from 6 mice: three controls and three ACTH treated and processed by the microarray team at Ark Genomics and the Roslin Institute. <br>RNAs were processed through standard Affymetrix protocols, with one round of cDNA amplification. Processed RNAs were hybridised to Affymetrix Mouse Genome 430 2.0 GeneChip, and data were extracted through the GCOS software. <br>CEL files were made available for further data processing via RMA in Bioconductor.

2009-03-31 | E-MEXP-1761 | biostudies-arrayexpress

Interaction between diabetes and hypertension in a rat model of diabetic nephropathy

Project description:Fisher male Cyp1a1mRen2 rats were allocated into four groups of four biological replicates each: control; streptozotocin-induced diabetes alone; indole-3-carbinol induced hypertension alone; combined induced diabetes and hypertension. <br>Kidneys were harvested for microarray analysis.analysis.

2011-12-31 | E-MEXP-3165 | biostudies-arrayexpress

Transcription profiling of adipose tissue from mesenteric and subcutaneous depots from 11beta-HSD1 knockout and wild type mice

Project description:Adipose tissue from mesenteric and subcutaneous depots from 11beta-HSD1 knockout (KO) and wild-type (WY) mice. Five biological replicates in each group: mesenteric KO, mesenteric WT, subcutaneous KO, subcutaneous WT.

2009-03-31 | E-MEXP-1636 | biostudies-arrayexpress

Transcription profiling by array of human dendritic cells co-cultured with carcinoma cells or treated with lipopolysaccharide

Project description:Human dendritic cells were co-cultured with carcinoma cells (A549 or SK-MES-1) or were treated with lipopolysaccharide (LPS).<br>There were three biological replicates of each condition plus untreated controls giving 12 samples and microarrays in total.<br>Samples were processed with standard Affymetrix IVT protocols and hybridised to Affymetrix Human Genome U133 GeneChips. Data were processed in Bioconductor using RMA.

2009-02-27 | E-MEXP-1958 | biostudies-arrayexpress

Diabetes and hypertension then reversal in a rat model of diabetic nephropathy

Project description:Fisher male Cyp1a1mRen2 rats were allocated into three groups of four or eight biological replicates each: control; combined induced diabetes and hypertension; removal of combined treatments. Kidneys were harvested for gene expression microarray analysis on Affymetrix GeneChip Rat Genome 230 2.0 GeneChips

2013-04-10 | E-MEXP-3739 | biostudies-arrayexpress

Polygenic architecture informs potential vulnerability to drug-induced liver injury

Project description:Drug-Induced-Liver-Injury (DILI) is a leading cause of termination in drug development programs and removal of drugs from the market because of inability to identify potential patients prior to clinical testing. Here, we approached a polygenic risk score (PRS) based strategy by aggregating effects of numerous genome-wide loci identified from previous large-scale genome-wide association studies (GWAS). The PRS predicted the susceptibility to DILI in patients in a clinical trial, and in multi-donor derived primary hepatocytes and stem cell-derived organoids. Pathway analysis highlighted processes previously implicated in DILI, including unfolded protein responses and oxidative stress alleviated by a potent antioxidant. Furthermore, hepatocytic transcriptomic signatures related to polygenic score identified potential drugs with clinical DILI evidence through in silico 941 compound screening. This genetic-, cellular-, organoid- and human-scale evidence underscored the polygenic architectures underlying DILI vulnerability at the level of hepatocytes, thus facilitating future mechanistic studies. Moreover, the proposed “polygenicity-in-a-dish” strategy potentially will contribute to prospective designs of safer, more efficient, and robust clinical trials.

2020-09-07 | GSE152447 | GEO

Genetic background of the polygenic neural tube defect

Project description:In polygenic disorders we do not know exactly, how many genes are involved in the pathomechanism, but the analysis of fetal gene expression can get us closer to the solution. In our study we were searching for the genetic background of the polygenic neural tube defect, which is the second most common birth defect in the world (1 in 1000 live births). Our data revealed novel candidate genes, like SLAP, LST1 and BENE, which can play an important role in the pathogenesis of neural tube defects. We created a data warehouse from the results, suitable for further analysis. This study also demonstrates that a routinely collected amount of amniotic fluid (as small as 6 mL) is enough to successfully hybridize isolated RNA to expression arrays, making the ability to use the technique from normally collected amniotic fluid samples. Keywords: Prenatal gene expression signature

2006-11-02 | GSE4182 | GEO

Polygenic control of developmental timing in vertebrates

Project description:Polygenic control of developmental timing in vertebrates

| PRJEB59222 | ENA

Schizophrenia-associated methylomic variation: molecular signatures of disease and polygenic risk burden across multiple brain regions (striatum DBCBB).

Project description:Genetic association studies provide evidence for a substantial polygenic component to schizophrenia, although the neurobiological mechanisms underlying the disorder remain largely undefined. Building on recent studies supporting a role for developmentally regulated epigenetic variation in the molecular etiology of schizophrenia, this study aimed to identify epigenetic variation associated with both a diagnosis of schizophrenia and elevated polygenic risk burden for the disease across multiple brain regions. Genome-wide DNA methylation was quantified in 262 post-mortem brain samples, representing tissue from four brain regions (prefrontal cortex, striatum, hippocampus and cerebellum) from 41 schizophrenia patients and 47 controls. We identified multiple disease-associated and polygenic risk score-associated differentially methylated positions and regions, many residing in the vicinity of genes previously implicated in schizophrenia including NCAM1, SYNPO, GBP4, PRDM9, GADD45B and DISC1. Our study represents the first analysis of epigenetic variation associated with schizophrenia across multiple brain regions and highlights the utility of polygenic risk scores for identifying molecular pathways associated with etiological variation in complex disease.

2016-11-10 | GSE89705 | GEO

Schizophrenia-associated methylomic variation: molecular signatures of disease and polygenic risk burden across multiple brain regions (hippocampus LNDBB).

2016-11-10 | GSE89703 | GEO